Skip to main content

Life Sciences

By Jessica Hagen | 02:32 pm | November 04, 2024
The CRISPR therapy, HG202, was conceived using AI and machine learning and aims to treat individuals with neovascular age-related macular degeneration.
By Anthony Vecchione | 03:16 pm | November 01, 2024
MedAware's AI-enabled platform allows pharmacists and clinical care personnel to intervene with medication dosages and therapy changes before potential harm occurs.
By Anthony Vecchione | 03:14 pm | October 31, 2024
Physicians will have the ability to compare medication prices in real-time and prescribe using eNavvi's platform.  
By Anthony Vecchione | 03:48 pm | October 30, 2024
ProPhet's aim is to bring down the time and cost of finding molecules for new drug targets.  
By Jessica Hagen | 11:34 am | October 29, 2024
Cuban told MobiHealthNews that he advocates for Harris because she announced she would take on non-pass-through PBMs and introduce drug transparency.
By Anthony Vecchione | 06:12 pm | October 28, 2024
The partnership aims to increase health practitioners' capabilities to master 10 essential cardiac views.  
By Anthony Vecchione | 02:45 pm | October 25, 2024
The alliance aims to improve the possibility of long-term effective donor recipient matching by adding haplotyping.
By Adam Ang | 11:45 am | October 25, 2024
Also, Dozee has unveiled a new RPM solution targeting non-resident Indians and their elderly.
By Anthony Vecchione | 04:22 pm | October 23, 2024
The aim of the collaboration is to improve outcomes for children with cancer and provide a platform for startups.
By Anthony Vecchione | 03:42 pm | October 23, 2024
The funds will be used to bolster research into emerging viruses that could become pandemics.